Understanding Phantosmia: When Your Brain Creates Smells That Aren't There

by Tammy L. Davis

Imagine smelling smoke when there's no fire, perceiving a persistent metallic odor that no one else detects, or experiencing burning scents when you're nowhere near a stove. This phenomenon—phantosmia or olfactory hallucination—affects approximately 5-6% of adults and can significantly impact quality of life.

Unlike parosmia, where real smells are distorted, phantosmia involves perceiving odors in the complete absence of any external source. These phantom smells can't be "masked" because they originate within the brain itself rather than from environmental stimuli.

What Phantom Smells Feel Like

Most people experiencing phantosmia report unpleasant odors. Research examining phantom smell characteristics found the most common descriptions include burning smells (the single most frequent), smoke (cigar, wood, or general), metallic or chemical odors, and rotten or foul smells. Less commonly, some report pleasant phantom scents. The hallucinations can occur in one nostril (unirhinal) or both (birhinal), and the pattern can provide clues about underlying causes.

What Causes Phantosmia?

Phantosmia can arise from disruptions anywhere along the olfactory pathway—from the nose to brain processing centers. Researchers classify causes as peripheral (arising from the nasal olfactory system) or central (originating in brain regions processing smell information).

Common causes include post-infectious olfactory dysfunction (following upper respiratory infections or COVID-19), head trauma (even mild), aging, neurological conditions (migraine, temporal lobe epilepsy, Parkinson's disease), sinonasal diseases (chronic sinusitis, nasal polyps), certain medications, and idiopathic cases where no clear cause is identified.

The Neuroscience Behind Phantom Smells

Recent research has identified something remarkable: phantosmia is associated with measurable brain chemistry changes. Specifically, people experiencing phantosmia show decreased levels of GABA (gamma-aminobutyric acid) in the cingulate cortex, amygdala, and insula.

GABA is your brain's primary inhibitory neurotransmitter—the brake pedal preventing neurons from firing excessively. When GABA levels decrease, certain brain regions become hyperactive, potentially generating spontaneous sensory perceptions without actual stimuli. When patients received treatments enhancing GABA activity, their phantom smells resolved and brain imaging showed GABA levels returning toward normal. This suggests phantosmia isn't psychological—it reflects genuine neurochemical changes that can be measured and potentially corrected.

Phantosmia and Related Conditions

Phantosmia doesn't always occur in isolation. Important connections include:

Migraine: Phantom smells can occur as a rare migraine aura, typically lasting 5-60 minutes before or alongside headache onset, affecting approximately 0.1-0.7% of migraine sufferers.

Epilepsy: Olfactory hallucinations are well-documented in temporal lobe epilepsy, serving as warning signs (auras) before seizures.

Depression and Anxiety: Patients with severe depression show enhanced rates of both parosmia and phantosmia, suggesting mood disorders affect olfactory processing through shared neurochemical pathways.

Diagnosis and Treatment

Proper evaluation typically includes medical history, physical examination, standardized olfactory testing (like "Sniffin' Sticks"), and imaging (MRI or CT scans) to rule out structural abnormalities.

Treatment effectiveness varies by underlying cause, but research identifies several promising approaches:

Root Cause Treatment: A systematic review found 73% of patients receiving treatment targeting underlying causes (antimigraine medications, antipsychotics for psychiatric causes, anticonvulsants for seizure-related phantosmia) experienced long-lasting relief, compared to only 32% with observation alone. This emphasizes the importance of identifying and treating root causes.

Medications Enhancing GABA: Given the documented GABA-phantosmia connection, medications enhancing GABAergic function—certain antipsychotics, anticonvulsants, and antidepressants affecting GABAergic transmission—have shown effectiveness.

Migraine Prophylaxis: For phantosmia occurring as migraine aura, standard migraine prevention strategies often reduce or eliminate olfactory hallucinations.

Plant Chemistry Meets Neuroscience: Essential Oils and GABA

Given phantosmia's connection to reduced GABA activity, peer-reviewed research has examined how specific plant-derived compounds might support healthy GABAergic function. Multiple studies using electrophysiological techniques demonstrate that certain essential oil constituents enhance GABA activity through precise receptor interactions:

Linalool (found in lavender, coriander seed, ho wood): Research in Frontiers in Chemistry using patch-clamp electrophysiology demonstrated that linalool enhances GABAergic currents through allosteric modulation at GABA_A receptors—specifically the α1β2γ2 receptor subtype representing 65% of all GABAergic neurons. This isn't vague "relaxation"—it's documented receptor activity with measurable effects on neuronal inhibition.

What makes this more intriguing: when you inhale or ingest linalool, your liver and lungs actively metabolize it into derivatives including 8-oxolinalool and 8-oxo-1,2-dihydrolinalool, which themselves show positive modulatory effects at GABA receptors. Your body isn't passively receiving these compounds—it's transforming them into forms that enhance GABAergic function.

Additional research has shown linalool inhalation produces measurable sedative effects through GABAergic mechanisms, reduces anxiety-like behaviors, and modulates stress-response genes.

Jasmine constituents: Research showed that cis-jasmone, jasmine lactone, linalool oxide, and methyl jasmonate significantly potentiate GABA response. In animal studies, inhalation of just 0.1% cis-jasmone or methyl jasmonate significantly increased sedation time.

Common essential oils: Studies using transfected cells expressing specific GABA receptor subtypes found lavender, basil, and chamomile exhibited positive modulation resulting in up to 98% increased GABAergic responses at receptors containing the γ2 subunit—the same receptor configuration mediating sedative and anxiolytic effects.

Lemongrass: Research demonstrated anxiolytic activity completely reversed when researchers administered flumazenil (a drug blocking benzodiazepine effects), proving lemongrass essential oil's calming effects occur via the GABA_A receptor-benzodiazepine complex—where anti-anxiety medications work, but through natural modulation.

Alpha and Beta-Pinene: Research published in Molecular Pharmacology demonstrated that α-pinene enhances non-rapid eye movement sleep in mice through GABA_A-benzodiazepine receptors. Studies on β-pinene showed it acts as an active principle in antidepressant effects.

Beta-Myrcene: Research shows beta-myrcene demonstrates sedative-hypnotic effects through the serotonergic synaptic pathway and upregulates GABA receptors while increasing expression of GABA synthesis enzymes.

The Critical Importance of Purity and Biochemical Individuality

Studies demonstrating GABA modulation used pure, analytically verified compounds at specific concentrations. Adulterated oils, synthetic fragrances, or products with unknown chemical profiles cannot be expected to produce the same neurological effects. Gas chromatography-mass spectrometry (GC-MS) analysis should verify that label claims match bottle contents.

Research shows different essential oils demonstrate receptor subtype-dependent allosteric modulation. Some constituents positively modulate synaptic GABA receptors while negatively modulating extrasynaptic receptors. This means the exact same oil might enhance one person's GABAergic function while having minimal—or opposite—effects in another, depending on individual receptor expression patterns, metabolic enzyme activity, and current neurochemical state.

This explains why generic aromatherapy protocols often disappoint. The lavender profoundly calming one person might do nothing for their friend—not because of placebo effects or quality issues, but because of fundamental biochemical individuality.

Important Caveats

Essential oil constituents should be viewed as complementary to, not replacements for, appropriate medical evaluation and treatment. If experiencing phantosmia: seek proper medical evaluation first, continue prescribed medications unless your physician recommends changes, work with qualified practitioners understanding both neuroscience and clinical application, use only pure analytically verified oils, and recognize that individual responses vary.

Living With Phantosmia: Practical Strategies

While pursuing treatment, many find these strategies helpful: use air purifiers to minimize environmental odors, maintain good nasal hygiene, stay well-hydrated, connect with others experiencing similar symptoms through WTSA's community, and keep a journal noting when phantosmia occurs and potential triggers.

When to Seek Immediate Medical Attention

While usually not dangerous, certain warning signs warrant prompt evaluation: sudden onset with neurological symptoms (weakness, vision changes, confusion, speech difficulties), association with severe unusual headache, combination with seizure activity or lost consciousness, or progressive worsening with additional neurological symptoms.

You're Not Alone

If you're experiencing phantosmia, you're part of a community. While the condition can feel isolating, thousands navigate this challenge daily. Your phantom smells have a neurochemical basis, deserve medical attention, and multiple evidence-based approaches exist to help. Organizations like the World Taste & Smell Association connect individuals experiencing sensory disorders, provide evidence-based information, and advocate for increased research and clinical awareness.

If you're experiencing persistent phantosmia, consult with an otolaryngologist or a neurologist familiar with olfactory disorders for proper evaluation and treatment planning.